Variant report
Variant | esv1810687 |
---|---|
Chromosome Location | chr9:6729601-6739489 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:180)
- CpG islands (count:61)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:6731623-6731673 | NT2-D1 | testis: | n/a |
2 | chr9:6731623-6731673 | NB4 | blood: | n/a |
3 | chr9:6731623-6731673 | AG09319 | gingival: | n/a |
4 | chr9:6731623-6731673 | HMEC | breast: | n/a |
5 | chr9:6731623-6731673 | HRCEpiC | kidney: | n/a |
6 | chr9:6731623-6731673 | LNCaP | prostate: | n/a |
7 | chr9:6731623-6731673 | Caco-2 | colon: | n/a |
8 | chr9:6731623-6731673 | HEEpiC | esophagus: | n/a |
9 | chr9:6731623-6731673 | SKMC | muscle: | n/a |
10 | chr9:6731623-6731673 | GM12892 | blood: | n/a |
11 | chr9:6731623-6731673 | Hela-S3 | cervix: | n/a |
12 | chr9:6731623-6731673 | AG10803 | skin: | n/a |
13 | chr9:6731623-6731673 | HRPEpiC | eye: | n/a |
14 | chr9:6731623-6731673 | BJ | skin: | n/a |
15 | chr9:6731623-6731673 | HIPEpiC | eye: | n/a |
16 | chr9:6731623-6731673 | AG09309 | skin: | n/a |
17 | chr9:6731623-6731673 | SK-N-SH | brain: | n/a |
18 | chr9:6731623-6731673 | IMR90 | lung: | fetal |
19 | chr9:6731623-6731673 | HAEpiC | amniotic membrane: | n/a |
20 | chr9:6731623-6731673 | HUVEC | blood vessel: | n/a |
21 | chr9:6731623-6731673 | HEK293 | kidney: | embryo |
22 | chr9:6731623-6731673 | NHDF-neo | bronchial: | n/a |
23 | chr9:6731623-6731673 | PANC-1 | pancreas: | n/a |
24 | chr9:6731623-6731673 | MCF10A-Er-Src | breast: | n/a |
25 | chr9:6731623-6731673 | GM19239 | blood: | n/a |
26 | chr9:6731623-6731673 | HCM | heart: | n/a |
27 | chr9:6731623-6731673 | AoSMC | blood vessel: | n/a |
28 | chr9:6731623-6731673 | GM06990 | blood: | n/a |
29 | chr9:6731623-6731673 | Hepatocyte | liver: | n/a |
30 | chr9:6731623-6731673 | ECC-1 | luminal epithelium: | n/a |
31 | chr9:6731623-6731673 | U87 | brain: | n/a |
32 | chr9:6731623-6731673 | T-47D | breast: | n/a |
33 | chr9:6731623-6731673 | HCPEpiC | choroid plexus: | n/a |
34 | chr9:6731623-6731673 | A549 | lung: | n/a |
35 | chr9:6731623-6731673 | HepG2 | liver: | n/a |
36 | chr9:6731623-6731673 | RPTEC | kidney: | n/a |
37 | chr9:6731623-6731673 | PFSK-1 | brain: | n/a |
38 | chr9:6731623-6731673 | ProgFib | skin: | n/a |
39 | chr9:6731623-6731673 | HRE | kidney: | n/a |
40 | chr9:6731623-6731673 | NH-A | brain: | n/a |
41 | chr9:6731623-6731673 | MCF-7 | breast: | n/a |
42 | chr9:6731623-6731673 | HPAEpiC | pulmonary alveolar: | n/a |
43 | chr9:6731623-6731673 | Jurkat | blood: | n/a |
44 | chr9:6731623-6731673 | ovcar-3 | ovarian: | n/a |
45 | chr9:6731623-6731673 | PrEC | prostate: | n/a |
46 | chr9:6731623-6731673 | GM12891 | blood: | n/a |
47 | chr9:6731623-6731673 | SAEC | small airway: | n/a |
48 | chr9:6731623-6731673 | BE2_C | brain: | n/a |
49 | chr9:6731623-6731673 | HL-60 | blood: | n/a |
50 | chr9:6731623-6731673 | K562 | blood: | n/a |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SNRPEP2-1 | chr9:6734598-6735076 | NONHSAT130163 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000231108 | TF binding region |
ENSG00000231108 | CpG island |
ENSG00000225489 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574505649 | chr9:6729605-6729606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185786669 | chr9:6729639-6729640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190686301 | chr9:6729644-6729645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527378894 | chr9:6729697-6729698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150234789 | chr9:6729746-6729747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182497481 | chr9:6729768-6729769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138912450 | chr9:6729823-6729824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550086213 | chr9:6729831-6729832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62566468 | chr9:6729927-6729928 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs552829045 | chr9:6729928-6729929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62566469 | chr9:6729930-6729931 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs547759149 | chr9:6729949-6729950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62566470 | chr9:6729951-6729952 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs539897965 | chr9:6729973-6729974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558818527 | chr9:6730015-6730016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs202182030 | chr9:6730118-6730119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142942724 | chr9:6730119-6730120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577127370 | chr9:6730120-6730121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141853418 | chr9:6730187-6730188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62566471 | chr9:6730216-6730217 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs574743914 | chr9:6730217-6730218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185304007 | chr9:6730249-6730250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115619716 | chr9:6730274-6730275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375798516 | chr9:6730275-6730276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572080791 | chr9:6730316-6730317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147121766 | chr9:6730354-6730355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs36111586 | chr9:6730363-6730364 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs553921543 | chr9:6730374-6730375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543571165 | chr9:6730381-6730382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs367796161 | chr9:6730391-6730392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562086209 | chr9:6730403-6730404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201729418 | chr9:6730414-6730415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35465144 | chr9:6730445-6730446 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs544978872 | chr9:6730463-6730464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373818432 | chr9:6730470-6730471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566047709 | chr9:6730475-6730476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191432356 | chr9:6730476-6730477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551927234 | chr9:6730481-6730482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34640702 | chr9:6730507-6730508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538046985 | chr9:6730540-6730541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556391599 | chr9:6730549-6730550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199525576 | chr9:6730551-6730552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376454998 | chr9:6730577-6730578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34693373 | chr9:6730587-6730588 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs535724761 | chr9:6730592-6730593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182450975 | chr9:6730602-6730603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs36043237 | chr9:6730628-6730629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572031778 | chr9:6730646-6730647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561041650 | chr9:6730649-6730650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187923210 | chr9:6730704-6730705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Dyslexia | 22102821 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Schizophrenia | 23813976 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:6724200-6749200 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr9:6725200-6734600 | Weak transcription | GM12878-XiMat | blood |
3 | chr9:6726800-6737800 | Weak transcription | Liver | Liver |
4 | chr9:6732600-6733800 | Enhancers | HepG2 | liver |
5 | chr9:6733200-6734200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr9:6733400-6733600 | Flanking Bivalent TSS/Enh | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr9:6738600-6739800 | Enhancers | Primary B cells from peripheral blood | blood |